Skip to main content

Find Clinical Trials

Home
Conditions
Neonatal Abstinence Syndrome

Clinical trial condition

Neonatal Abstinence Syndrome

Explore clinical trials studying Neonatal Abstinence Syndrome. Study availability and eligibility vary by location and protocol.

55 public trials 4 recruiting studies

Refine in advanced search Browse all conditions

Neonatal Abstinence Syndrome trial results

Completed

Optimal Morphine Dosing Schedule for Neonatal Abstinence Syndrome

NCT04298853

Conditions: Chemically-Induced Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infant, Newborn, Diseases, +5 more
Locations: Indiana University Health Methodist Hospital Indianapolis, Indiana, United States

View Trial Details

Completed

Can Ondansetron Prevent Neonatal Abstinence Syndrome (NAS) in Babies Born to Narcotic-dependent Women

NCT01965704

Conditions: Chemically-Induced Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infant, Newborn, Diseases, +5 more
Locations: UCSF, San Francisco General Hospital San Francisco, California, United States

Santa Clara Valley Medical Center San Jose, California, United States

Stanford University Medical Center Stanford, California, United States

University of Louisville Louisville, Kentucky, United States

View Trial Details

Completed

Buprenorphine Pharmacometric Open Label Research Study of Drug Exposure

NCT03608696

Conditions: Chemically-Induced Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infant, Newborn, Diseases, +4 more
Locations: Thomas Jefferson University Hosptial Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Clonidine Versus Phenobarbital as Adjunctive Therapy for Neonatal Abstinence Syndrome

NCT03670160

Conditions: Chemically-Induced Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infant, Newborn, Diseases, +3 more
Locations: University of Tennessee Medical Center Knoxville, Tennessee, United States

View Trial Details

Completed

Assessing the Effects of Auricular Acupressure on Newborns With NAS

NCT03890562

Conditions: Chemically-Induced Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infant, Newborn, Diseases, +3 more
Locations: Virginia Commonwealth University Richmond, Virginia, United States

View Trial Details

Completed

Blinded Trial of Buprenorphine or Morphine in the Treatment of the Neonatal Abstinence Syndrome

NCT01452789

Conditions: Chemically-Induced Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infant, Newborn, Diseases, +3 more
Locations: Thomas Jefferson University Hosptial Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Feasibility of Auricular Acupressure as an Adjunct Treatment for Neonatal Abstinence Syndrome (NAS)

NCT03973801

Conditions: Chemically-Induced Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infant, Newborn, Diseases, +4 more
Locations: Vanderbilt University Medical Center Nashville, Tennessee, United States

View Trial Details

Completed

How to Treat Opiate Withdrawal in Neonates

NCT02810782

Conditions: Chemically-Induced Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infant, Newborn, Diseases, +5 more
Locations: Not specified

View Trial Details

Completed

Improving Outcomes in Neonatal Abstinence Syndrome

NCT01958476

Conditions: Chemically-Induced Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infant, Newborn, Diseases, +4 more
Locations: Shands Jacksonville Medical Center Jacksonville, Florida, United States

Maine Medical Center Portland, Maine, United States

Tufts Medical Center Boston, Massachusetts, United States

Boston Medical Center Boston, Massachusetts, United States

View Trial Details

Completed

Weighted Blankets With Infants With NAS

NCT03113656

Conditions: Chemically-Induced Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infant, Newborn, Diseases, +3 more
Locations: Good Samaritan Hospital Cincinnati, Ohio, United States

View Trial Details